Impact of an infection consultation service for bacteraemia on clinical management and use of resources

QJM : Monthly Journal of the Association of Physicians
D NathwaniD Parratt

Abstract

Since 1993, the infection consultation service for bacteraemia has seen 310 patients in the Medical and Surgical Directorates at Ninewells Hospital and Kings Cross Hospital. A random sample of 100 was audited. Case-notes were incomplete for five patients, leaving 95 fully-audited patients. Clinical outcome measures were death from infection, and readmission within 2 weeks of discharge. Initial treatment was inconsistent with antibiotic policy in 46 patients (48%). Antibiotic treatment was changed in 37 (80%) of these patients: increased in intensity in 19 (41%) and decreased in 18 (39%). Changes were also made in 30 (61%) of the 49 patients whose initial treatment was consistent with sepsis policy-increased in seven (14%) and decreased in 23 (47%). Median daily antibiotic costs were lowered in patients whose initial treatment was consistent with sepsis policy (pounds 10.10 vs. pounds 7.28, p = 0.0274). However, in the other patients, savings were balanced by increases (p = 0.7696). Consultation required one consultant session per week (3.5 h) and the audit required an additional 16 consultant sessions. Seven patients died, but only one death was directly related to infection. Six patients were readmitted to hospital within 2 we...Continue Reading

Citations

Apr 9, 2005·Der Internist·M Battegay, U Flückiger
Dec 31, 2010·Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer·G PongasDimitrios P Kontoyiannis
Jan 4, 2001·International Journal of Antimicrobial Agents·I C Gyssens
Mar 7, 2001·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·D NathwaniP Davey
Apr 10, 2003·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Russell M PetrakR Brooks Gainer
May 6, 2004·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Marvin J Tenenbaum
Oct 16, 2004·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Emilio BouzaJuan Garcia Lechuz
Oct 16, 2004·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Burke A Cunha
Feb 16, 2005·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Eoghan O'NeillEdmond Smyth
Aug 13, 2013·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Guillaume BéraudFrederic F Rahbari-Oskoui
Feb 23, 2008·BMJ : British Medical Journal·Jane MintonMark Wilcox
Sep 23, 2008·QJM : Monthly Journal of the Association of Physicians·P LillieG Barlow
Oct 11, 2012·Infectious Diseases in Clinical Practice : IDCP·Alexa A PragmanGregory A Filice
Mar 8, 2011·La Presse médicale·Philippe LespritChristian Brun-Buisson
Apr 7, 2004·Acta Clinica Belgica·S Blot, K Vandewoude
Nov 20, 1998·The Journal of Infection·D Nathwani, P Davey
May 7, 2015·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Sameer S KadriNaomi P O'Grady
May 31, 2015·Diagnostic Microbiology and Infectious Disease·Richard S P HuangAudrey Wanger
Feb 16, 2002·The Journal of Hospital Infection·G BarlowD Nathwani
Sep 18, 2004·Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases·A BorerF Schlaeffer
Oct 20, 2007·Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases·S Blot
Mar 25, 2015·Journal of Chemotherapy·Silvano EspositoMario Venditti
Feb 5, 2000·The Journal of Hospital Infection·D Nathwani
Mar 15, 2006·The Journal of Antimicrobial Chemotherapy·H M ZiglamD Nathwani
Nov 20, 2016·European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology·M SasikumarP Brouqui

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.